P-301 Benefit of adding bevacizumab to trifluridine/tipiracil in different prognostic groups of metastatic colorectal cancer: A Portuguese exploratory analysis
Title:
P-301 Benefit of adding bevacizumab to trifluridine/tipiracil in different prognostic groups of metastatic colorectal cancer: A Portuguese exploratory analysis
Author:
Roque, R. Coelho, A. Brasil, S. Santos, R. Antunes Santos, L. Gomes, I. Fraga, T. Caetano, A. Paulo, J. Bonito, N.